Related Experiment Videos
Radioactive sputter cathodes for 32P plasma-based ion implantation
M A Fortin1, R W Paynter, A Sarkissian
1INRS-EMT (Université du Québec), 1650 boul. Lionel Boulet, Varennes, Québec, Canada J3X 1S2. fortin@bms.uu.se
Summary
Plasma-based radioactive ion implantation (PBRII) enhances nuclear medicine treatments. Coating substrates with iron improves radioisotope distribution for efficient activation of biomedical devices.
Area of Science:
- Nuclear Medicine
- Biomedical Engineering
- Materials Science
Background:
- Beta-emitting devices are increasingly used in nuclear medicine for clinical treatments.
- Current methods for activating these devices face challenges with efficiency and uniform radioisotope distribution.
- Novel plasma-based techniques offer potential for improved radioactive ion implantation.
Purpose of the Study:
- To evaluate the efficiency of plasma-based radioactive ion implantation (PBRII) for biomedical devices.
- To investigate the impact of radioisotope distribution on PBRII efficiency.
- To develop an improved technique for uniform 32P distribution in biomedical implants.
Main Methods:
- Design and testing of a pulsed, coaxial electron cyclotron resonance plasma reactor for PBRII.
- Fabrication of sputter targets using dilute orthophosphoric acid (H3(32)PO4).
- Application of an iron coating to substrates to improve radioisotope distribution.
Main Results:
- PBRII demonstrated higher implantation efficiencies for radioisotopes (32P) compared to conventional ion beams.
- Nonuniform distribution of 32P on substrates reduced PBRII efficiency.
- Iron coating of substrates resulted in improved radioisotope sputtering rates and uniform 32P distribution.
Conclusions:
- PBRII is a feasible and efficient method for implanting radioisotopes into biomedical devices.
- Optimizing radioisotope distribution, through techniques like iron coating, is crucial for maximizing PBRII efficiency.
- This technique facilitates the efficient activation of millimetric biomedical devices, such as stents and coils, for clinical applications.